Intralesional collagenase injections in patients with Peyronie's disease: do they IMPRESS and can we afford them?

Publisher： John Wiley & Sons Inc

E-ISSN： 1464-410x|116|4|503-504

ISSN： 1464-4096

Source： BJU INTERNATIONAL, Vol.116, Iss.4, 2015-10, pp. : 503-504

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Analysis of the clinical safety of intralesional injection of collagenase Clostridium histolyticum (CCH) for adults with Peyronie's disease (PD)

By  

BJU INTERNATIONAL, Vol. 116, Iss. 5, 2015-11 ,pp. : 815-822

John Wiley & Sons Inc

Access to resources Recommend Favorite

Analysis of the clinical safety of intralesional injection of collagenase Clostridium histolyticum (CCH) for adults with Peyronie's disease (PD)

By  

BJU INTERNATIONAL, Vol. 1464-4096, Iss. 5, 2015-11 ,pp. : 815-822

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antimicrobial stewardship – can we afford to do without it?

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 79, Iss. 2, 2015-02 ,pp. : 173-181

John Wiley & Sons Inc

Access to resources Recommend Favorite

CCH Phase 3 Open‐Label Study

By  

THE JOURNAL OF SEXUAL MEDICINE, Vol. 12, Iss. 1, 2015-01 ,pp. : 248-258

John Wiley & Sons Inc

Access to resources Recommend Favorite

Can We Afford the War on Cancer?

By  

Oncology Research and Treatment, Vol. 31, Iss. 3, 2008-02 ,pp. : 81-81

Karger

Access to resources Recommend Favorite